<rdf:RDF xmlns:api="http://www.elsevier.com/xml/svapi/rdf/dtd/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/84868012506"><dc:identifier>https://api.elsevier.com/content/abstract/eid/2-s2.0-84868012506</dc:identifier><api:scopusId>84868012506</api:scopusId><api:eid>2-s2.0-84868012506</api:eid><api:pubmedId>22730028</api:pubmedId><api:pui>365949728</api:pui><prism:doi>10.1002/art.34584</prism:doi><dc:title>Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): Ten-year experience at a single center</dc:title><prism:issn>00043591</prism:issn><prism:issn>15290131</prism:issn><prism:contentType>Abstract</prism:contentType><prism:aggregationType>Journal</prism:aggregationType><api:srctype>j</api:srctype><api:subtype>ar</api:subtype><api:subtypeDescription>Article</api:subtypeDescription><api:citedbyCount>166</api:citedbyCount><prism:publicationName>Arthritis and Rheumatism</prism:publicationName><api:sourceId>19140</api:sourceId><prism:volume>64</prism:volume><prism:issueIdentifier>11</prism:issueIdentifier><prism:startingPage>3770</prism:startingPage><prism:endingPage>3778</prism:endingPage><prism:pageRange>3770-3778</prism:pageRange><prism:coverDate>2012-11-01</prism:coverDate><prism:copyrightYear>2012</prism:copyrightYear><dc:creator><rdf:Seq><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/22033670300"><api:authid>22033670300</api:authid><api:surname>Cartin-Ceba</api:surname><api:givenName>Rodrigo</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60005558"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/16022102600"><api:authid>16022102600</api:authid><api:surname>Golbin</api:surname><api:givenName>Jason M.</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60005558"/><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/113157534"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/6602502450"><api:authid>6602502450</api:authid><api:surname>Keogh</api:surname><api:givenName>Karina A.</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60005558"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/6603395824"><api:authid>6603395824</api:authid><api:surname>Peikert</api:surname><api:givenName>Tobias</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60005558"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/55441594300"><api:authid>55441594300</api:authid><api:surname>Sánchez-Menéndez</api:surname><api:givenName>Marta</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/112617601"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/7003494524"><api:authid>7003494524</api:authid><api:surname>Ytterberg</api:surname><api:givenName>Steven R.</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60005558"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/6701686142"><api:authid>6701686142</api:authid><api:surname>Fervenza</api:surname><api:givenName>Fernando C.</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60005558"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/7005264715"><api:authid>7005264715</api:authid><api:surname>Specks</api:surname><api:givenName>Ulrich</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60005558"/></api:Author></rdf:li></rdf:Seq></dc:creator><dc:subject rdf:resource="http://data.elsevier.com/vocabulary/ASJC/2403"/><dc:subject rdf:resource="http://data.elsevier.com/vocabulary/ASJC/2723"/><dc:subject rdf:resource="http://data.elsevier.com/vocabulary/ASJC/2745"/><dc:subject rdf:resource="http://data.elsevier.com/vocabulary/ASJC/2736"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0028158243"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/34250840592"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0026505235"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0038122889"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/12544253745"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0018869708"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0020051506"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0033065098"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0035674612"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/12344330217"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/20144368363"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/31944440872"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/33749331884"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/33750214245"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/67650094918"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/77955767712"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/77954651554"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/77954632414"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0025183423"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0031201034"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/20844443668"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/1642545105"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0035053927"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0036266879"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/33646104678"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/77749277070"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/36248938220"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/58149251788"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/19944427673"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0019181878"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/2942537697"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/79952064528"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/16544381960"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/2942518018"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/33646480336"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0042847159"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0030028656"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/77950314505"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/67650951478"/><api:scopusPage rdf:resource="https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&amp;scp=84868012506&amp;origin=inward"/></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/affiliation/affiliation_id/60005558"><api:afid>60005558</api:afid><skos:prefLabel>Mayo Clinic</skos:prefLabel></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/affiliation/affiliation_id/113157534"><api:afid>113157534</api:afid><skos:prefLabel>Long Island Lung Center</skos:prefLabel></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/affiliation/affiliation_id/112617601"><api:afid>112617601</api:afid><skos:prefLabel>Centro Médico de Asturias</skos:prefLabel></rdf:Description><rdf:Description rdf:about="http://data.elsevier.com/vocabulary/ASJC/2403"><api:code>2403</api:code><api:abbrev>IMMU</api:abbrev><skos:prefLabel>Immunology</skos:prefLabel><skos:altLabel>Immunology and Microbiology</skos:altLabel></rdf:Description><rdf:Description rdf:about="http://data.elsevier.com/vocabulary/ASJC/2723"><api:code>2723</api:code><api:abbrev>MEDI</api:abbrev><skos:prefLabel>Immunology and Allergy</skos:prefLabel><skos:altLabel>Medicine</skos:altLabel></rdf:Description><rdf:Description rdf:about="http://data.elsevier.com/vocabulary/ASJC/2745"><api:code>2745</api:code><api:abbrev>MEDI</api:abbrev><skos:prefLabel>Rheumatology</skos:prefLabel><skos:altLabel>Medicine</skos:altLabel></rdf:Description><rdf:Description rdf:about="http://data.elsevier.com/vocabulary/ASJC/2736"><api:code>2736</api:code><api:abbrev>MEDI</api:abbrev><skos:prefLabel>Pharmacology (medical)</skos:prefLabel><skos:altLabel>Medicine</skos:altLabel></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0028158243"><api:scopusId>0028158243</api:scopusId><dc:title>Nomenclature of systemic vasculitides: Proposal of an international consensus conference</dc:title><prism:publicationName>Arthritis Rheum</prism:publicationName><prism:publicationYear>1994</prism:publicationYear><prism:volume>37</prism:volume><prism:startingPage>187</prism:startingPage><prism:endingPage>192</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/34250840592"><api:scopusId>34250840592</api:scopusId><dc:title>ANCA are detectable in nearly all patients with active severe Wegener's granulomatosis</dc:title><prism:publicationName>Am J Med</prism:publicationName><prism:publicationYear>2007</prism:publicationYear><prism:volume>120</prism:volume></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0026505235"><api:scopusId>0026505235</api:scopusId><dc:title>Wegener granulomatosis: An analysis of 158 patients</dc:title><prism:publicationName>Ann Intern Med</prism:publicationName><prism:publicationYear>1992</prism:publicationYear><prism:volume>116</prism:volume><prism:startingPage>488</prism:startingPage><prism:endingPage>498</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0038122889"><api:scopusId>0038122889</api:scopusId><dc:title>A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies</dc:title><prism:publicationName>N Engl J Med</prism:publicationName><prism:publicationYear>2003</prism:publicationYear><prism:volume>349</prism:volume><prism:startingPage>36</prism:startingPage><prism:endingPage>44</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/12544253745"><api:scopusId>12544253745</api:scopusId><dc:title>Etanercept plus standard therapy for Wegener's granulomatosis</dc:title><prism:publicationName>N Engl J Med</prism:publicationName><prism:publicationYear>2005</prism:publicationYear><prism:volume>352</prism:volume><prism:startingPage>351</prism:startingPage><prism:endingPage>361</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0018869708"><api:scopusId>0018869708</api:scopusId><dc:title>Activation of human B lymphocytes</dc:title><prism:publicationName>XII. Differential Effects of in Vitro Cyclophosphamide on Human Lymphocyte Subpopulations Involved in B Cell Activation. Immunology</prism:publicationName><prism:publicationYear>1980</prism:publicationYear><prism:volume>39</prism:volume><prism:startingPage>391</prism:startingPage><prism:endingPage>397</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0020051506"><api:scopusId>0020051506</api:scopusId><dc:title>Suppression of human B lymphocyte function by cyclophosphamide</dc:title><prism:publicationName>J Immunol</prism:publicationName><prism:publicationYear>1982</prism:publicationYear><prism:volume>128</prism:volume><prism:startingPage>2453</prism:startingPage><prism:endingPage>2457</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0033065098"><api:scopusId>0033065098</api:scopusId><dc:title>Differential B- and T-cell activation in Wegener's granulomatosis</dc:title><prism:publicationName>J Allergy Clin Immunol</prism:publicationName><prism:publicationYear>1999</prism:publicationYear><prism:volume>103</prism:volume><prism:startingPage>885</prism:startingPage><prism:endingPage>894</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0035674612"><api:scopusId>0035674612</api:scopusId><dc:title>Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy</dc:title><prism:publicationName>Arthritis Rheum</prism:publicationName><prism:publicationYear>2001</prism:publicationYear><prism:volume>44</prism:volume><prism:startingPage>2836</prism:startingPage><prism:endingPage>2840</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/12344330217"><api:scopusId>12344330217</api:scopusId><dc:title>Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis</dc:title><prism:publicationName>Arthritis Rheum</prism:publicationName><prism:publicationYear>2005</prism:publicationYear><prism:volume>52</prism:volume><prism:startingPage>262</prism:startingPage><prism:endingPage>268</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/20144368363"><api:scopusId>20144368363</api:scopusId><dc:title>Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab</dc:title><prism:publicationName>J Intern Med</prism:publicationName><prism:publicationYear>2005</prism:publicationYear><prism:volume>257</prism:volume><prism:startingPage>540</prism:startingPage><prism:endingPage>548</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/31944440872"><api:scopusId>31944440872</api:scopusId><dc:title>Rituximab for refractory Wegener's granulomatosis: Report of a prospective, open-label pilot trial</dc:title><prism:publicationName>Am J Respir Crit Care Med</prism:publicationName><prism:publicationYear>2006</prism:publicationYear><prism:volume>173</prism:volume><prism:startingPage>180</prism:startingPage><prism:endingPage>187</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/33749331884"><api:scopusId>33749331884</api:scopusId><dc:title>Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re-treatment</dc:title><prism:publicationName>Arthritis Rheum</prism:publicationName><prism:publicationYear>2006</prism:publicationYear><prism:volume>54</prism:volume><prism:startingPage>2970</prism:startingPage><prism:endingPage>2982</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/33750214245"><api:scopusId>33750214245</api:scopusId><dc:title>Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab</dc:title><prism:publicationName>Rheumatology (Oxford)</prism:publicationName><prism:publicationYear>2006</prism:publicationYear><prism:volume>45</prism:volume><prism:startingPage>1432</prism:startingPage><prism:endingPage>1436</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/67650094918"><api:scopusId>67650094918</api:scopusId><dc:title>A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis</dc:title><prism:publicationName>Arthritis Rheum</prism:publicationName><prism:publicationYear>2009</prism:publicationYear><prism:volume>60</prism:volume><prism:startingPage>2156</prism:startingPage><prism:endingPage>2168</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/77955767712"><api:scopusId>77955767712</api:scopusId><dc:title>Rituximab as maintenance therapy for anti-neutrophil cytoplasmic antibody-associated vasculitis</dc:title><prism:publicationName>Clin J Am Soc Nephrol</prism:publicationName><prism:publicationYear>2010</prism:publicationYear><prism:volume>5</prism:volume><prism:startingPage>1394</prism:startingPage><prism:endingPage>1400</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/77954651554"><api:scopusId>77954651554</api:scopusId><dc:title>Rituximab versus cyclophosphamide for ANCA-associated vasculitis</dc:title><prism:publicationName>N Engl J Med</prism:publicationName><prism:publicationYear>2010</prism:publicationYear><prism:volume>363</prism:volume><prism:startingPage>221</prism:startingPage><prism:endingPage>232</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/77954632414"><api:scopusId>77954632414</api:scopusId><dc:title>Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis</dc:title><prism:publicationName>N Engl J Med</prism:publicationName><prism:publicationYear>2010</prism:publicationYear><prism:volume>363</prism:volume><prism:startingPage>211</prism:startingPage><prism:endingPage>220</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0025183423"><api:scopusId>0025183423</api:scopusId><dc:title>The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis</dc:title><prism:publicationName>Arthritis Rheum</prism:publicationName><prism:publicationYear>1990</prism:publicationYear><prism:volume>33</prism:volume><prism:startingPage>1101</prism:startingPage><prism:endingPage>1107</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0031201034"><api:scopusId>0031201034</api:scopusId><dc:title>Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: Initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group</dc:title><prism:publicationName>Mayo Clin Proc</prism:publicationName><prism:publicationYear>1997</prism:publicationYear><prism:volume>72</prism:volume><prism:startingPage>737</prism:startingPage><prism:endingPage>747</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/20844443668"><api:scopusId>20844443668</api:scopusId><dc:title>Prolonged treatment of refractory Wegener's granulomatosis with 15-deoxyspergualin: An open study in seven patients</dc:title><prism:publicationName>Nephrol Dial Transplant</prism:publicationName><prism:publicationYear>2005</prism:publicationYear><prism:volume>20</prism:volume><prism:startingPage>1083</prism:startingPage><prism:endingPage>1092</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/1642545105"><api:scopusId>1642545105</api:scopusId><dc:title>Treatment of refractory Wegener's granulomatosis with antithymocyte globulin (ATG): An open study in 15 patients</dc:title><prism:publicationName>Kidney Int</prism:publicationName><prism:publicationYear>2004</prism:publicationYear><prism:volume>65</prism:volume><prism:startingPage>1440</prism:startingPage><prism:endingPage>1448</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0035053927"><api:scopusId>0035053927</api:scopusId><dc:title>A disease-specific activity index for Wegener's granulomatosis: Modification of the Birmingham Vasculitis Activity Score</dc:title><prism:publicationName>Arthritis Rheum</prism:publicationName><prism:publicationYear>2001</prism:publicationYear><prism:volume>44</prism:volume><prism:startingPage>912</prism:startingPage><prism:endingPage>920</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0036266879"><api:scopusId>0036266879</api:scopusId><dc:title>Detection of anti-neutrophil cytoplasmic antibodies under actual clinical testing conditions</dc:title><prism:publicationName>Clin Immunol</prism:publicationName><prism:publicationYear>2002</prism:publicationYear><prism:volume>103</prism:volume><prism:startingPage>196</prism:startingPage><prism:endingPage>203</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/33646104678"><api:scopusId>33646104678</api:scopusId><dc:title>Comparison of a multiplex, bead-based fluorescent assay and immunofluorescence methods for the detection of ANA and ANCA autoantibodies in human serum</dc:title><prism:publicationName>J Immunol Methods</prism:publicationName><prism:publicationYear>2006</prism:publicationYear><prism:volume>311</prism:volume><prism:startingPage>189</prism:startingPage><prism:endingPage>197</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/77749277070"><api:scopusId>77749277070</api:scopusId><dc:title>Mycophenolate mofetil for induction and maintenance of remission in microscopic polyangiitis with mild to moderate renal involvement-a prospective, open-label pilot trial</dc:title><prism:publicationName>Clin J Am Soc Nephrol</prism:publicationName><prism:publicationYear>2010</prism:publicationYear><prism:volume>5</prism:volume><prism:startingPage>445</prism:startingPage><prism:endingPage>453</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/36248938220"><api:scopusId>36248938220</api:scopusId><dc:title>Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis</dc:title><prism:publicationName>Ann Intern Med</prism:publicationName><prism:publicationYear>2007</prism:publicationYear><prism:volume>147</prism:volume><prism:startingPage>611</prism:startingPage><prism:endingPage>619</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/58149251788"><api:scopusId>58149251788</api:scopusId><dc:title>Relapsed Wegener's granulomatosis after rituximab therapy-B cells are present in new pathological lesions despite persistent 'depletion' of peripheral blood</dc:title><prism:publicationName>Nephrol Dial Transplant</prism:publicationName><prism:publicationYear>2008</prism:publicationYear><prism:volume>23</prism:volume><prism:startingPage>3030</prism:startingPage><prism:endingPage>3032</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/19944427673"><api:scopusId>19944427673</api:scopusId><dc:title>Importance of cellular microenvironment and circulatory dynamics in B cell immunotherapy</dc:title><prism:publicationName>J Immunol</prism:publicationName><prism:publicationYear>2005</prism:publicationYear><prism:volume>174</prism:volume><prism:startingPage>817</prism:startingPage><prism:endingPage>826</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0019181878"><api:scopusId>0019181878</api:scopusId><dc:title>Effect of chemotherapeutic agents on natural and BCG-stimulated macrophage cytotoxicity in mice</dc:title><prism:publicationName>Int J Immunopharmacol</prism:publicationName><prism:publicationYear>1980</prism:publicationYear><prism:volume>2</prism:volume><prism:startingPage>333</prism:startingPage><prism:endingPage>339</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/2942537697"><api:scopusId>2942537697</api:scopusId><dc:title>Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis</dc:title><prism:publicationName>N Engl J Med</prism:publicationName><prism:publicationYear>2004</prism:publicationYear><prism:volume>350</prism:volume><prism:startingPage>2572</prism:startingPage><prism:endingPage>2581</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/79952064528"><api:scopusId>79952064528</api:scopusId><dc:title>Pneumocystis jiroveci pneumonia following rituximab treatment in Wegener's granulomatosis</dc:title><prism:publicationName>Arthritis Care Res (Hoboken)</prism:publicationName><prism:publicationYear>2010</prism:publicationYear><prism:volume>62</prism:volume><prism:startingPage>1661</prism:startingPage><prism:endingPage>1664</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/16544381960"><api:scopusId>16544381960</api:scopusId><dc:title>Regulatory roles for cytokine-producing B cells in infection and autoimmune disease</dc:title><prism:publicationName>Curr Dir Autoimmun</prism:publicationName><prism:publicationYear>2005</prism:publicationYear><prism:volume>8</prism:volume><prism:startingPage>25</prism:startingPage><prism:endingPage>54</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/2942518018"><api:scopusId>2942518018</api:scopusId><dc:title>Pneumocystis pneumonia</dc:title><prism:publicationName>N Engl J Med</prism:publicationName><prism:publicationYear>2004</prism:publicationYear><prism:volume>350</prism:volume><prism:startingPage>2487</prism:startingPage><prism:endingPage>2498</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/33646480336"><api:scopusId>33646480336</api:scopusId><dc:title>B cells are required for generation of protective effector and memory CD4 cells in response to Pneumocystis lung infection</dc:title><prism:publicationName>J Immunol</prism:publicationName><prism:publicationYear>2006</prism:publicationYear><prism:volume>176</prism:volume><prism:startingPage>6147</prism:startingPage><prism:endingPage>6154</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0042847159"><api:scopusId>0042847159</api:scopusId><dc:title>Clearance of Pneumocystis carinii in mice is dependent on B cells but not on P carinii-specific antibody</dc:title><prism:publicationName>J Immunol</prism:publicationName><prism:publicationYear>2003</prism:publicationYear><prism:volume>171</prism:volume><prism:startingPage>1423</prism:startingPage><prism:endingPage>1430</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0030028656"><api:scopusId>0030028656</api:scopusId><dc:title>Pneumocystis carinii infection in transgenic B cell-deficient mice</dc:title><prism:publicationName>J Infect Dis</prism:publicationName><prism:publicationYear>1996</prism:publicationYear><prism:volume>173</prism:volume><prism:startingPage>1034</prism:startingPage><prism:endingPage>1037</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/77950314505"><api:scopusId>77950314505</api:scopusId><dc:title>Rituximab-associated neutropenia</dc:title><prism:publicationName>Semin Hematol</prism:publicationName><prism:publicationYear>2010</prism:publicationYear><prism:volume>47</prism:volume><prism:startingPage>180</prism:startingPage><prism:endingPage>186</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/67650951478"><api:scopusId>67650951478</api:scopusId><dc:title>Serum immunoglobulins and risk of infection: How low can you go?</dc:title><prism:publicationName>Semin Arthritis Rheum</prism:publicationName><prism:publicationYear>2009</prism:publicationYear><prism:volume>39</prism:volume><prism:startingPage>18</prism:startingPage><prism:endingPage>29</prism:endingPage></rdf:Description></rdf:RDF>